☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Blueprint
Blueprint Presents Proof-of-Concept Data of BLU-945 in P-I/II (SYMPHONY) Trial for EGFR-Mutant Non-Small Cell Lung Cancer at AACR...
April 11, 2022
Blueprint Collaborated with Proteovant to Advance Novel Targeted Protein Degrader Therapies
March 1, 2022
PharmaShots Weekly Snapshots (July 13- 17, 2020)
July 20, 2020
Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20
June 1, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
